Quantitative analysis of mast cells in benign and malignant colonic lesions: Immunohistochemical study on formalin-fixed, paraffin-embedded tissues

Allergologia et Immunopathologia

Volumn 36, Issue 5, 2008, Pages 271-276

  Kashiwase, Y ^a   Inamura, H ^a   Morioka, J ^a   Igarashi, Y ^a   Kawai Kowase, K ^a   Kurosawa, Motohiro ^a  

^a Shin Ohra Hospital   (Japan)

Author keywords

Colonic cancer; Inflammatory bowel disease; Mast cell; Tryptase; Ulcerative colitis

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PRIMARY TUMOR; QUANTITATIVE ANALYSIS; REMISSION; ULCERATIVE COLITIS;

EID: 57749117399     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/S0301-0546(08)75222-4     Document Type: Article

References (25)

1. Barczyk M, Debek W, Chyczewski L. Mast cells in the gastrointestinal tract. Rocz Akad Med Bialymst. 1995;40:36-57.
2. Sulik A, Kemona A, Sulik M, Oldak E. The gastrointestinal mast cell in health and disease. Rocz Akad Med Bialymst. 1999;44:17-23.
3. Simu G, Csaba G. Mast cells in tumor-bearing patients. Acta Morphol Acad Sci Hung. 1972;20:327-38.
4. Svennevig JL, Lunde OC, Holter J. In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol Microbiol Immunol Scand [A]. 1982;90:131-7.
5. Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M. Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum. 1995;38:290-3.
6. Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM. Enhancement of human mast cell mediator release in active ulcerative colitis. Gastroenterology. 1990;99:119-24.
7. King T, Biddle W, Bhatia P. Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci. 1992;4:490-5.
8. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28:1-13.
9. Lloyd G, Gren HY, Fox H, Mani V, Turnberg LA. Mast cell and immunoglobulin E in inflammatory bowel disease. Gut. 1975;16:861-6.
10. Craig SS, DeBlois G, Schwartz LB. Mast cells in human keloid, small intestine, and lung by immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol. 1986;124:427-35.
11. Sasaki Y, Tanaka M, Kudo H. Differentiation between ulcerative colitis and Crohn's disease by a quantitative Immunohistochemical evaluation of T lymphocytes, neutrophils, histiocytes and mast cells. Pathol Int. 2002;52:277-85.
12. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology. 2002;49:678-82.
13. Inamura H, Kashiwase Y, Morioka J, Suzuki K, Igarashi Y, Kurosawa M. Accumulation of mast cells in the interstitium of eosinophilic colitis. Allergol et Immunopathol. 2006;34:228-30.
14. Kashiwase Y, Morioka J, Inamura H, Yoshizawa Y, Usui R, Kurosawa M. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int Arch Allergy Immunol. 2004;134:199-205.
15. Chapuis PH, Dent OF, Newland RC, Bokey EL, Pheils MT. An evaluation of the American Joint Committee (pTNM) staging method for cancer of the colon and rectum. Dis Colon Rectum. 1986;29:6-10.
16. Shivananda S, Hordijk ML, Ten Kate FJ, Probert CS, Mayberry JF. Differential diagnosis of inflammatory bowel disease. A comparison of various diagnostic classifications. Scand J Gastroenterol. 1991;26:167-73.
17. Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal antitryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37:1509-15.
18. Cordell J, Falini B, Erber W, Ghosh AK, Abdulaziz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984;32:219-29.
19. Benfield GFA, Bryan R, Crocker J. Lamina propria eosinophils and mast cells in ulcerative colitis: comparison between Asians and Caucasians. J Clin Pathol. 1990;43:27-31.
20. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol. 1989;20:159-63.
21. Acikalin MF, Oner U, Topcu I, Yasar B, Kiper H, Colak E. Tumor angiogenesis and mast cell density in the prognostic assessment of colorectal carcinoma. Dig Liver Dis. 2005;37:162-9.
22. Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol. 2007;20:1-11.
23. Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y, Zhao LJ. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol. 2005;28:1210-4.
24. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DAF. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci. 1990;35:1409-13.
25. Irani AM, Craig SS, DeBlois G, Elson CO, Schechter NM, Schwartz LB. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol. 1987;138:4381-6.